RXO (RXO) Reports In-Line Q4 EPS; offers guidance

RXO (NYSE: RXO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.66 billion.

RXO expects first-quarter 2025 adjusted EBITDA to be between $20 million and $30 million. The company expects first-quarter 2025 Brokerage gross margin to be between 12% and 14%.

For earnings history and earnings-related data on RXO (RXO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS